Suppr超能文献

遗传降低 mTOR 表达后,哺乳动物寿命延长,以及部分组织和器官衰老速度减缓。

Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression.

机构信息

Center for Molecular Medicine, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Cell Rep. 2013 Sep 12;4(5):913-20. doi: 10.1016/j.celrep.2013.07.030. Epub 2013 Aug 29.

Abstract

We analyzed aging parameters using a mechanistic target of rapamycin (mTOR) hypomorphic mouse model. Mice with two hypomorphic (mTOR(Δ/Δ)) alleles are viable but express mTOR at approximately 25% of wild-type levels. These animals demonstrate reduced mTORC1 and mTORC2 activity and exhibit an approximately 20% increase in median survival. While mTOR(Δ/Δ) mice are smaller than wild-type mice, these animals do not demonstrate any alterations in normalized food intake, glucose homeostasis, or metabolic rate. Consistent with their increased lifespan, mTOR(Δ/Δ) mice exhibited a reduction in a number of aging tissue biomarkers. Functional assessment suggested that, as mTOR(Δ/Δ) mice age, they exhibit a marked functional preservation in many, but not all, organ systems. Thus, in a mammalian model, while reducing mTOR expression markedly increases overall lifespan, it affects the age-dependent decline in tissue and organ function in a segmental fashion.

摘要

我们使用雷帕霉素靶蛋白(mTOR)功能减弱的小鼠模型来分析衰老参数。具有两个功能减弱(mTOR(Δ/Δ))等位基因的小鼠是有活力的,但表达的 mTOR 约为野生型水平的 25%。这些动物表现出 mTORC1 和 mTORC2 活性降低,中位生存期延长约 20%。虽然 mTOR(Δ/Δ)小鼠比野生型小鼠小,但这些动物的标准化食物摄入量、葡萄糖稳态或代谢率没有任何改变。与它们的寿命延长一致,mTOR(Δ/Δ)小鼠表现出许多衰老组织生物标志物的减少。功能评估表明,随着 mTOR(Δ/Δ)小鼠衰老,它们在许多(但不是全部)器官系统中表现出明显的功能保存。因此,在哺乳动物模型中,尽管降低 mTOR 的表达显著增加了整体寿命,但它以节段性的方式影响组织和器官功能随年龄的下降。

相似文献

1
Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression.
Cell Rep. 2013 Sep 12;4(5):913-20. doi: 10.1016/j.celrep.2013.07.030. Epub 2013 Aug 29.
2
Depletion of Rictor, an essential protein component of mTORC2, decreases male lifespan.
Aging Cell. 2014 Oct;13(5):911-7. doi: 10.1111/acel.12256. Epub 2014 Jul 25.
3
mTOR as Regulator of Lifespan, Aging, and Cellular Senescence: A Mini-Review.
Gerontology. 2018;64(2):127-134. doi: 10.1159/000484629. Epub 2017 Dec 1.
6
mTORC2-SGK-1 acts in two environmentally responsive pathways with opposing effects on longevity.
Aging Cell. 2014 Oct;13(5):869-78. doi: 10.1111/acel.12248. Epub 2014 Jul 9.
7
Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity.
Science. 2012 Mar 30;335(6076):1638-43. doi: 10.1126/science.1215135.
8
Sex- and tissue-specific changes in mTOR signaling with age in C57BL/6J mice.
Aging Cell. 2016 Feb;15(1):155-66. doi: 10.1111/acel.12425. Epub 2015 Nov 24.
9
Dissecting mammalian target of rapamycin to promote longevity.
Rejuvenation Res. 2012 Jun;15(3):334-7. doi: 10.1089/rej.2012.1347.

引用本文的文献

2
mTOR Modulates NLRP3 Inflammasome Activation via Nuclear Translocation and STAT1 Inhibition.
Eur J Immunol. 2025 Jun;55(6):e51176. doi: 10.1002/eji.202451176.
3
Hyperactivation of mTORC1 by an endogenous gain-of-function mutation does not reduce lifespan in .
MicroPubl Biol. 2025 Apr 25;2025. doi: 10.17912/micropub.biology.001520. eCollection 2025.
4
Design principles of gene circuits for longevity.
Trends Cell Biol. 2025 Mar 12. doi: 10.1016/j.tcb.2025.02.006.
5
Citrulline regulates macrophage metabolism and inflammation to counter aging in mice.
Sci Adv. 2025 Mar 7;11(10):eads4957. doi: 10.1126/sciadv.ads4957.
6
An mTOR inhibitor discovery system using drug-sensitized yeast.
Geroscience. 2025 Jan 30. doi: 10.1007/s11357-025-01534-8.
7
9
Glia: the cellular glue that binds circadian rhythms and sleep.
Sleep. 2025 Mar 11;48(3). doi: 10.1093/sleep/zsae314.
10
The role of mechanosignaling in the control of myocardial mass.
Am J Physiol Heart Circ Physiol. 2025 Mar 1;328(3):H622-H638. doi: 10.1152/ajpheart.00277.2024. Epub 2024 Dec 31.

本文引用的文献

1
Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells.
Nat Med. 2012 Jul;18(7):1095-101. doi: 10.1038/nm.2793.
2
Rapamycin slows aging in mice.
Aging Cell. 2012 Aug;11(4):675-82. doi: 10.1111/j.1474-9726.2012.00832.x. Epub 2012 Jun 4.
3
Regulation and function of mTOR signalling in T cell fate decisions.
Nat Rev Immunol. 2012 Apr 20;12(5):325-38. doi: 10.1038/nri3198.
4
mTOR signaling in growth control and disease.
Cell. 2012 Apr 13;149(2):274-93. doi: 10.1016/j.cell.2012.03.017.
5
Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity.
Science. 2012 Mar 30;335(6076):1638-43. doi: 10.1126/science.1215135.
6
Protein oxidative modification in the aging organism and the role of the ubiquitin proteasomal system.
Curr Pharm Des. 2011 Dec 1;17(36):4007-22. doi: 10.2174/138161211798764898.
7
mTOR signaling in disease.
Curr Opin Cell Biol. 2011 Dec;23(6):744-55. doi: 10.1016/j.ceb.2011.09.003. Epub 2011 Sep 29.
8
Age sensitivity of behavioral tests and brain substrates of normal aging in mice.
Front Aging Neurosci. 2011 May 25;3:9. doi: 10.3389/fnagi.2011.00009. eCollection 2011.
9
Ubiquitin-proteasome pathway and cellular responses to oxidative stress.
Free Radic Biol Med. 2011 Jul 1;51(1):5-16. doi: 10.1016/j.freeradbiomed.2011.03.031. Epub 2011 Apr 8.
10
mTOR: from growth signal integration to cancer, diabetes and ageing.
Nat Rev Mol Cell Biol. 2011 Jan;12(1):21-35. doi: 10.1038/nrm3025. Epub 2010 Dec 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验